The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 357:1199-1209 September 20, 2007 Number 12
NextNext

TRAF1–C5 as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study
Robert M. Plenge, M.D., Ph.D., Mark Seielstad, Ph.D., Leonid Padyukov, M.D., Ph.D., Annette T. Lee, Ph.D., Elaine F. Remmers, Ph.D., Bo Ding, Ph.D., Anthony Liew, M.S., Houman Khalili, B.S., Alamelu Chandrasekaran, Ph.D., Leela R.L. Davies, B.S., Wentian Li, Ph.D., Adrian K.S. Tan, M.Sc., Carine Bonnard, M.Sc., Rick T.H. Ong, M.Sc., Anbupalam Thalamuthu, Ph.D., Sven Pettersson, M.D., Ph.D., Chunyu Liu, Ph.D., Chao Tian, B.S., Wei V. Chen, M.S., John P. Carulli, Ph.D., Evan M. Beckman, M.D., David Altshuler, M.D., Ph.D., Lars Alfredsson, Ph.D., Lindsey A. Criswell, M.D., M.P.H., Christopher I. Amos, Ph.D., Michael F. Seldin, M.D., Ph.D., Daniel L. Kastner, M.D., Ph.D., Lars Klareskog, M.D., Ph.D., and Peter K. Gregersen, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-PowerPoint Slide Set
-Supplementary Material

Commentary
-Editorial
 by Yamamoto, K.

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
ABSTRACT

Background Rheumatoid arthritis has a complex mode of inheritance. Although HLA-DRB1 and PTPN22 are well-established susceptibility loci, other genes that confer a modest level of risk have been identified recently. We carried out a genomewide association analysis to identify additional genetic loci associated with an increased risk of rheumatoid arthritis.

Methods We genotyped 317,503 single-nucleotide polymorphisms (SNPs) in a combined case–control study of 1522 case subjects with rheumatoid arthritis and 1850 matched control subjects. The patients were seropositive for autoantibodies against cyclic citrullinated peptide (CCP). We obtained samples from two data sets, the North American Rheumatoid Arthritis Consortium (NARAC) and the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA). Results from NARAC and EIRA for 297,086 SNPs that passed quality-control filters were combined with the use of Cochran–Mantel–Haenszel stratified analysis. SNPs showing a significant association with disease (P<1x10–8) were genotyped in an independent set of case subjects with anti–CCP-positive rheumatoid arthritis (485 from NARAC and 512 from EIRA) and in control subjects (1282 from NARAC and 495 from EIRA).

Results We observed associations between disease and variants in the major-histocompatibility-complex locus, in PTPN22, and in a SNP (rs3761847) on chromosome 9 for all samples tested, the latter with an odds ratio of 1.32 (95% confidence interval, 1.23 to 1.42; P=4x10–14). The SNP is in linkage disequilibrium with two genes relevant to chronic inflammation: TRAF1 (encoding tumor necrosis factor receptor–associated factor 1) and C5 (encoding complement component 5).

Conclusions A common genetic variant at the TRAF1–C5 locus on chromosome 9 is associated with an increased risk of anti–CCP-positive rheumatoid arthritis.


Source Information

The authors' affiliations are listed in the Appendix.

Drs. Plenge and Seielstad contributed equally to this article. Drs. Klareskog and Gregersen contributed equally to this article as principal investigators for the Swedish Epidemiological Investigation of Rheumatoid Arthritis and the North American Rheumatoid Arthritis Consortium, respectively.

This article (10.1056/NEJMoa073491) was published at www.nejm.org on September 5, 2007.

Address reprint requests to Dr. Gregersen at the Feinstein Institute for Medical Research, 350 Community Dr., Manhasset, NY 11030, or at peterg{at}nshs.edu.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.